Stony Brook Biomedical Discovery Advances New Approach to Pain Relief Without Opioids
As the United States continues to confront the long-term consequences of opioid addiction and chronic pain, biomedical researchers at the State University of New York at Stony Brook are helping...Read More
Non-Opioid Pain Therapy Discovered at Stony Brook Advances with $11 Million Private Investment
A novel, non-opioid pain drug candidate originating from research at the State University of New York at Stony Brook has reached a significant milestone, as Artelo Biosciences announced on March...Read More
Drug to Treat Neuropathy Advances in Clinical Trials
A compound originally developed at SBU now in clinical development A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study’s...Read More
